Search results
Dr. Jeff Hersh addresses cause, effects and complications of Graft vs Host Disease
The Metrowest Daily News via Yahoo News· 2 days agoGraft vs Host Disease occurs when white blood cells produced by donated stem cells identify the...
Targeting leukemia's survival route: A novel approach to overcoming leukemia recurrence
Medical Xpress· 7 days agoResearchers from Karolinska Institutet have, in collaboration with the University of Eastern Finland and Lund University, published a study in Genome Biology demonstrating that targeting cell ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoLive from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety PR Newswire SUZHOU, China ...
New cancer treatment increases efficacy by injecting chemo directly into tumor cells
BGR· 19 hours agoChemotherapy has proven to be a fairly successful treatment for cancer. The Food and Drug...
Valrubicin-loaded immunoliposomes: A new technology to fight hematological cancer
Medical Xpress· 4 days agoValrubicin, a lipophilic chemical molecule similar to daunorubicin, has primarily been used in the treatment of bladder cancer. An article recently published in Cell Death & Disease ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoHONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I clinical trial of its menin inhibitor HMPL-506 in
At 17, She Fell in Love With a 47-Year-Old. Now She Questions the Story.
New York Times· 1 hour agoJill Ciment’s 1996 memoir “Half a Life” described her teenage affair with the man she eventually...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoOSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant At the American Transplant Congress 2024 (June 1-5 Philadelphia) Nantes, France – June 5, 2024,
ABC7's Eileen Whelan Shares Her Visionaries of the Year Fundraiser | 97.1 WASH-FM
iHeartRadio· 4 days agoABC7's Eileen Whelan shares her visionaries of the year fundraiser and could use your last minute...
MD Anderson Research Highlights for June 5, 2024 | Newswise
Newswise· 5 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These